1.     Technologies to deliver therapeutics across the blood brain barrier - a            common barrier for treating many brain diseases.

2.     Technologies to help optimize therapies that are most likely to benefit               selected patients - often referred to as personalized medicine.

3.     Molecularly targeted therapies that target the abnormal pathways                      implicated in a variety of brain related disorders.